ReviewFrontiers in neuroscience2026
MiR-7 in neurological disorders: beyond metabolic dysregulation.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain health depends on the fine coordination of metabolic and neuronal pathways, and disturbances in this balance are recognized as major drivers of neurodegenerative, neurological, and neuropsychiatric disorders. Increasing evidence indicates that microRNAs (miRNAs), as key post-transcriptional regulators of gene expression, play important roles in the molecular networks underlying neurological diseases by modulating pathways involved in energy metabolism, inflammation, oxidative stress, and neuronal survival. Among them, miR-7 has emerged as a particularly relevant regulator due to its high conservation, abundant expression in the central nervous system (CNS), and pleiotropic actions impacting both metabolic and neurodegenerative processes. This review focuses on current knowledge regarding miR-7 as a molecular node linking metabolic imbalance to neurological dysfunction, highlighting its regulatory targets and potential translational relevance in neurometabolic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.